Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial
Top Cited Papers
- 1 May 2015
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 385 (9983), 2173-2182
- https://doi.org/10.1016/s0140-6736(15)60164-7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Integrating Cryptococcal Antigen Screening and Pre-Emptive Treatment into Routine HIV CareJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic ReviewPLoS Medicine, 2011
- A Randomized Controlled Trial Comparing the Effects of Counseling and Alarm Device on HAART Adherence and Virologic OutcomesPLoS Medicine, 2011
- Cost‐Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV‐Infected Persons with a CD4+Cell Count ⩽100 Cells/μL Who Start HIV Therapy in Resource‐Limited SettingsClinical Infectious Diseases, 2010
- Effect of Peer Health Workers on AIDS Care in Rakai, Uganda: A Cluster-Randomized TrialPLOS ONE, 2010
- Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trialThe Lancet, 2009
- High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll outAIDS, 2009
- Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South AfricaClinical Infectious Diseases, 2009
- Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2008
- A systematic review of delay in the diagnosis and treatment of tuberculosisBMC Public Health, 2008